Navigation Links
Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
Date:3/23/2011

ere can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release. CONTACT: Amgen, Thousand Oaks Ashleigh Koss: (805) 313-6151 (media)Wendy Woods Williams: +41 (41) 3692 542 (E.U. media)Arvind Sood: (805) 447-1060 (investors)(1)  "Facts and
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
2. Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies
3. AstraZeneca Initiates Phase III Clinical Programme Evaluating NKTR-118 for Treatment of Opioid-Induced Constipation
4. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
5. The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
6. Los Angeles Dentist, Dr. Kevin Sands, Uses the Latest Technologies to Provide VIP Services and Treatments for His Patients
7. International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyongos Decision to Travel to the U.S. for Prostate Cancer Treatment
8. Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barretts Esophagus
9. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act of 2011
10. Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
11. Genus Oncology, LLC Announces Orphan Drug Status for GO-203-2c for Treatment of Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... N.J. , Nov. 21, 2014  PTC Therapeutics, Inc. ... the 2014 Legend of Technology Award for Vision, Innovation, and ... Ph.D., Chief Executive Officer. This award recognizes an individual who ... New Jersey for several decades. ... Technology Award," stated Stuart Peltz , Ph.D., CEO of ...
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... , Nov. 20, 2014 /CNW Telbec/ - KLOX ... announce the following appointments: Todd ... in the newly created role of Chief Commercial Officer, ... system using topical photoconverter gel for the treatment of ... and traumatic wounds, recently approved in Europe ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4
... , , HOUSTON , ... 16-year-old Francesco "Frank" De Santiago. On January 29 , ... transplant operation at Texas Children,s Heart Center . De ... child ever discharged from a pediatric hospital with an implanted ...
... , , KINGWOOD, Texas , Feb. ... announced today that the company has formally offered to purchase ... on selling in the chronic pain management medical sector. The ... not be identified until IMAI has a signed letter of ...
Cached Medicine Technology:Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 2Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 3International Merchant Advisors, Inc. Offers to Invest in Pharmaceutical Chain 2
(Date:11/23/2014)... 23, 2014 Wright & Schulte LLC ... Ohio and West Virginia residents who allege that they ... disorders due to drinking C8 contaminated water released ... Virginia. According to the C8 complaints, the plaintiffs were ... or lived in at least one of the six ...
(Date:11/22/2014)... November 23, 2014 Cancer researchers in ... connection between intercellular communication tunnels and the growth and ... full story on the Surviving Mesothelioma website. ... the University of Minnesota have just released their study ... and materials between cells. They found that mesothelioma ...
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in ... its new collection of bamboo mats ; the new ... off. , According to the sales manager of ... it a highly renewable resource. Their bamboo mats are 100% ... which comes from natural bamboo with caramel bamboo strips. ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 In order to ... new promotion of cocktail party dresses. The business knows that ... in social occasions. , Now, the party dresses ... to 70% off. As the leading company in fashion industry, ... favorite outfit for every customer. So it always raises the ...
(Date:11/22/2014)... SATURDAY, Nov. 22, 2014 (HealthDay News) -- The wide ... can pose a threat for people with food allergies, ... there are so many types of food allergies that ... over the holidays," Dr. Guha Krishnaswamy, director of allergy ... said in a hospital news release. "If you ...
Breaking Medicine News(10 mins):Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... Remain to Vote on the Proposed Merger, SOUTH SAN ... Dear VaxGen Stockholder, March 28th marks the date ... stockholder vote on the proposed VaxGen-Raven,merger. Your vote is important. ... votes cast in person or by proxy at the VaxGen ...
... March 20 Arthur J. Gallagher &,Co. ... Solutions, LLC,headquartered in Fort Washington, Pennsylvania. Terms ... in 2002, Healthcare Risk Solutions, LLC is ... insurance,products, associated risk mitigation consulting services and ...
... haze, scientists say , , THURSDAY, March 20 (HealthDay News) ... an important contributor to smog. , This chemical reaction ... dioxide (NO2) in "excited" states -- was long assumed ... University of California, San Diego, conclude that it,s actually ...
... Peake: Health Care Closer for Veterans, WASHINGTON, March ... access to world-class health care under,a Department of Veterans ... 2008. Secretary of Veterans Affairs Dr. James B. Peake ... Kentucky,Illinois, Indiana, Oklahoma, Tennessee and Washington., "VA is ...
... a proactive follow-up care program designed to help ... of life, PALO ALTO, Calif., March 20 ... it is offering oncology treatment,centers a way to provide ... quality of life. Varian is teaming with,Cogent Health Solutions ...
... people felt better dispersing gifts than buying things for themselves , , ... buy happiness, at least when you spend it on others. ... 21 issue of Science . It found that spending ... , What,s more, most people seemed unaware of this ...
Cached Medicine News:Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 2Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 3Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 4Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 5Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 6Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 7Health News:Smog's Origins Get Clearer 2Health News:VA to Open 14 New Clinics in Seven States 2Health News:Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship 2Health News:Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship 3Health News:Give and Be Happy 2
... The ACON PSA Semi-Quantitative Prostate Specific Antigen ... are lateral flow tests in strip and ... Prostate Specific Antigen (PSA). The tests are ... cut-off values, and all come with a ...
Remote Control Vision Tester Can Administer Basic,Distance Vision Tests in Less Than 2 Minutes....
... Increase profitability by ... with simple test,sequences ... administered by ancillary ... than 5 minutes. ...
Holladay Contract Acuity Test provides a more sensitive evaluation for testing visual functions than standard acuity charts....
Medicine Products: